Sandoval Elisabeth

Sandoval Elisabeth is listed in filings as Director at PROCEPT BioRobotics Corporation. This profile follows SEC Form 4 activity through Jun 12, 2025, including 3 public disclosures. Recent filings connect the profile to PROCEPT BioRobotics Corporation (PRCT) and VYNE Therapeutics Inc. (VYNE). The current snapshot covers public activity from Dec 13, 2024 to Jun 12, 2025. Reported amounts are shown as $178.0K to $48.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.